LGND NASDAQ
Ligand Pharmaceuticals Incorporated
1W: +0.5%
1M: +5.6%
3M: -5.5%
YTD: +59.4%
1Y: +69.2%
3Y: +392.9%
5Y: +248.9%
$302.96
+0.22 (+0.07%)
Weekly Expected Move ±4.1%
$278
$290
$303
$315
$328
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$291M
Revenue
+54.9% YoY
$197M
Net Income
+360.0% YoY
$131M
Free Cash Flow
+229.2% YoY
95.0%
Gross Margin
13.5%
Op. Margin
76.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE22.0%
ROA12.6%
ROIC11.3%
Valuation
P/E30.3
P/B6.3
EV/EBITDA24.4
Leverage
Debt/Equity1.17
Current Ratio31.18
Interest Cov.45.4x
Quality Scores
Piotroski F5/9
Altman Z5.04
Beneish M-1.84